Oliver Hantschel (O Hantschel)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Tyrosine Kinase

Top Venues

Nature chemical biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea, Stacey Phan, Kaeli B Miller, Feifei Hu, Anjeli Mase, Yibing Shan, Oliver Hantschel, Matthew P Jacobson, Neil P Shah
BCR::ABL1 Kinase N-lobe Mutants Confer Moderate to High Degrees of Resistance to Asciminib. Blood (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Oliver Hantschel
The druggability of SH2 domains unmasked. Nature chemical biology 20 (3) (2024)
Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea, Stacey Phan, Kaeli B Miller, Feifei Hu, Anjeli Mase, Yibing Shan, Oliver Hantschel, Matthew P Jacobson, Neil P Shah
BCR::ABL1 Kinase N-lobe Mutants Confer Moderate to High Degrees of Resistance to Asciminib. Blood (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Oliver Hantschel
The druggability of SH2 domains unmasked. Nature chemical biology 20 (3) (2024)
Oliver Hantschel
The druggability of SH2 domains unmasked. Nature chemical biology (2024)
Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea, Stacey Phan, Kaeli B Miller, Feifei Hu, Anjeli Mase, Yibing Shan, Oliver Hantschel, Matthew P Jacobson, Neil P Shah
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Blood 144 (6) (2024)
Oliver Hantschel
The druggability of SH2 domains unmasked. Nature chemical biology 20 (3) (2024)
Nina Schmidt, Frank Abendroth, Olalla Vázquez, Oliver Hantschel
Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl. RSC chemical biology 3 (8) (2022)
Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola, Ana Tapia-Abellán, Sangeetha Shankar, Liudmila Andreeva, Matthew S J Mangan, Marianne Rebecca Spalinger, Hubert Kalbacher, Peter Duewell, Marta Lovotti, Karlotta Bosch, Sabine Dickhöfer, Ana Marcu, Stefan Stevanovic, Franziska Herster, Yamel Cardona Gloria, Tzu-Hsuan Chang, Francesca Bork, Carsten L Greve, Markus W Löffler, Olaf-Oliver Wolz, Nadine A Schilling, Jasmin Beate Kuemmerle-Deschner, Samuel Wagner, Anita Delor, Bodo Grimbacher, Oliver Hantschel, Michael Scharl, Hao Wu, Eicke Latz, Alexander N R Weber
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity. The Journal of experimental medicine 218 (11) (2021)
Georgios N Hatzopoulos, Tim Kükenshöner, Niccolò Banterle, Tatiana Favez, Isabelle Flückiger, Virginie Hamel, Santiago Andany, Georg Ernest Fantner, Oliver Hantschel, Pierre Gönczy
Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly. Nature communications 12 (1) (2021)
Grégory La Sala, Camille Michiels, Tim Kükenshöner, Tania Brandstoetter, Barbara Maurer, Akiko Koide, Kelvin Lau, Florence Pojer, Shohei Koide, Veronika Sexl, Laure Dumoutier, Oliver Hantschel
Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains. Nature communications 11 (1) (2020)
Daniel P Duarte, Allan J Lamontanara, Giuseppina La Sala, Sukyo Jeong, Yoo-Kyoung Sohn, Alejandro Panjkovich, Sandrine Georgeon, Tim Kükenshöner, Maria Jose Marcaida, Florence Pojer, Marco De Vivo, Dmitri I Svergun, Hak-Sung Kim, Matteo Dal Peraro, Oliver Hantschel
Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms. Nature communications 11 (1) (2020)
Afsar A Mian, Ines Baumann, Marcus Liebermann, Florian Grebien, Giulio Superti-Furga, Martin Ruthardt, Oliver G Ottmann, Oliver Hantschel
The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis. Leukemia 33 (9) (2019)
Nadine Eliane Schmit, Katyayanee Neopane, Oliver Hantschel
Targeted Protein Degradation through Cytosolic Delivery of Monobody Binders Using Bacterial Toxins. ACS chemical biology 14 (5) (2019)
Joseph M Taft, Sandrine Georgeon, Chris Allen, Sina Reckel, Joseph DeSautelle, Oliver Hantschel, George Georgiou, Brent L Iverson
Rapid Screen for Tyrosine Kinase Inhibitor Resistance Mutations and Substrate Specificity. ACS chemical biology 14 (9) (2019)
J Saarbach, E Lindberg, S Folliet, S Georgeon, Oliver Hantschel, Nicolas Winssinger
Kinase-templated abiotic reaction. Chemical science 8 (7) (2017)
Sina Reckel, Charlotte Gehin, Delphine Tardivon, Sandrine Georgeon, Tim Kükenshöner, Frank Löhr, Akiko Koide, Lena Buchner, Alejandro Panjkovich, Aline Reynaud, Sara Pinho, Barbara Gerig, Dmitri Svergun, Florence Pojer, Peter Güntert, Volker Dötsch, Shohei Koide, Anne-Claude Gavin, Oliver Hantschel
Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase. Nature communications 8 (1) (2017)